NEW YORK (GenomeWeb News) – Applied Proteomics said today that it has closed a $28 million Series C financing round.

The company plans to use the funds to support development and commercialization of its first proteomic diagnostic, a mass spectrometry-based blood test to aid in the early detection of colorectal cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.